Delivery Order SPE2DB20D1100-SPE2DB24FC5P5

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,447.19 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of a pharmaceutical product, the BREYNA 80-4.5 MCG INHALER 10.3GM, with a period of performance through December 18, 2024. The contract does not have a set-aside designation, indicating open competition. As a key vendor for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,653.85 firm fixed-price delivery order is for the supply of the pharmaceutical product BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $10,596.30 delivery order with a firm fixed price for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,643.30 firm-fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM, to the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $2,096.49 with a firm fixed price and a completion date of June 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM. The $1,037.70 firm fixed-price delivery order contract has an ultimate completion date of August 9, 2024. It is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA Troop Support...
This federal contract award, valued at $2,817.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of a pharmaceutical product, BREYNA 80-4.5 MCG INHALER 10.3GM, with an ultimate completion date of April 16, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,453.77, is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM medical devices. The award has a completion date of February 28, 2025 and is a firm-fixed price contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,213.10 Firm Fixed Price Delivery Order is for the supply of a pharmaceutical product, specifically the BREYNA 80-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,886.69 firm fixed-price delivery order is for the supply of a specific medical inhaler product, BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds two relevant Indefinite Delivery Contracts (IDCs) - one with the DLA Troop Support Medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC5P5
    Delivery Order

This federal contract award, valued at $14,658.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of a specific medication, BREYNA 160-4.5 MCG INHALER 10.3GM, with a completion date of July 3, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract does not have a set-aside designation.

Generated 10/1/24, 12:57 PM